SEC Form 4 · accession 0001082038-18-000010
DURECT CORP · DRRX
Statement of changes in beneficial ownership, as filed. Original on EDGAR ↗
Reporting owner
Michael Arenberg
Officer — Chief Financial Officer
Period of report
Oct 15, 2018
Accepted (ET)
Oct 17, 2018 · 8:43 pm EDT
Rule 10b5-1 plan
unknown — predates the checkbox
Issuer CIK
0001082038
Table I — non-derivative securities
No Table I lines on this filing.
Table II — derivative securities
| Security | Conv. / exercise price | Date | Code | Shares | A/D | Exercisable | Expires | Underlying | Underlying shares | Owned after | D/I |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Incentive Stock Option (right to buy)F1 | $0.972 | Oct 15, 2018 | A | 17,318 | A | Nov 15, 2018 | Oct 15, 2028 | Common Stock | 17,318 | 17,318 | D |
| Non-Qualified Stock Option (right to buy)F1 | $0.972 | Oct 15, 2018 | A | 32,682 | A | Nov 15, 2018 | Oct 15, 2028 | Common Stock | 32,682 | 32,682 | D |
Explanation of responses
- F1ISO/NQ Grants Dated October 15, 2018 combined will vest as follows: monthly over four years following the Grant Date.